Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials

Cardiovascular Drugs and Therapy

Volumn 16, Issue 5, 2002, Pages 411-415

  Clarke, Robert ^a   Armitage, Jane ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Antioxidant vitamins; Cardiovascular disease; Clinical trials

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE;

ATHEROGENIC DIET; ATHEROSCLEROSIS; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DIET; DIET SUPPLEMENTATION; FRUIT; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; PRIORITY JOURNAL; RISK MANAGEMENT; VEGETABLE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; BETA CAROTENE; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHOLESTEROL, LDL; HUMANS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; VITAMIN E; VITAMINS;

EID: 0036999106     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022134418372     Document Type: Conference Paper

References (21)

1. Doll R, Peto R. The Causes of Cancer. Oxford: Oxford University Press, 1981.
2. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-208.
3. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum J. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
4. Jialal I, Norkus EP, Cristol L, Grundy SM. Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1991;1086:34-38.
5. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992;85:2337-2344.
6. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arteriorscler Thromb 1993;13:590-600.
7. Steinberg D. Clinical trial of antioxidants in atherosclerosis: Are we doing the right thing? Lancet 1995;346:36-38.
8. Stamfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
9. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
10. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-1190.
11. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum, selenium, vitamin antioxidants and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462-468.
12. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-231.
13. Riemersma RA, Wood DA, MacIntyre CC, Elton RA, Gey KF, Oliver MR. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E and carotene. Lancet 1991;337:1-5.
14. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.
16. Hennekens C, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl Med J 1996;334:1145-1149.
17. Stephens NG, Parsons A, Scholfield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996;347:781-786.
18. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-1720.
19. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999;354:447-455.
20. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet 2002;357:89-95.
21. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000;342:154-160.